Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers March 27, 2015
Pharmacy Choice - News - U.S. Pharmaceutical Industry - March 27, 2015

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

3/27/15 - "Abuse Resistant Forms of Extended Release Oxymorphone, Method of Use and Method of Making" in Patent Application Approval Process
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors Shah, Manish S.; DiFalco, Ray J., filed on November 7, 2014, was made available online on March 12, 2015, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a company or ins
3/27/15 - Ariad and Medison Pharma Secures Approval of Iclusig in Israel [Health & Beauty Close - Up]
Ariad Pharmaceuticals and Medison Pharma reported that the Israeli Ministry of Health has granted regulatory approval for Iclusig in Israel. "Iclusig is an important addition to the treatment armamentarium," said Professor Arnon Nagler, head of hematology and the Bone Marrow Transplant Division at the Chaim Sheba Medical Center in Israel, and chai
3/27/15 - Boston Scientific Reports First U.S. Commercial Procedures with WATCHMAN Left Atrial Appendage Closure Device [Health & Beauty Close - Up]
Boston Scientific reported that three patients in the United States received the first implants of its WATCHMAN Left Atrial Appendage Closure Device. The WATCHMAN Device received U.S. Food and Drug Administration approval on Friday, March 13. "Boston Scientific is proud to work with physicians in making a meaningful impact on patient lives by brin
3/27/15 - Homeopathic Product Regulation: Evaluating the Food and Drug Administration's Regulatory Framework After a Quarter-Century; Public Hearing
SUMMARY: The Food and Drug Administration is announcing a public hearing to obtain information and comments from stakeholders about the current use of human drug and biological products labeled as homeopathic, as well as the Agency's regulatory framework for such products. FDA is seeking participants for the public hearing and written comments from
3/27/15 - Marin officials want drug companies to fund disposal of expired meds [The Marin Independent Journal, Novato, Calif.]
County supervisors, saying there are more overdose deaths from prescription drugs in Marin than heroin and cocaine combined, want county lawyers to come up with a law compelling drug firms catering to Marin residents to provide a "take back" program in order to get rid of unused medications. The move this week came at urging of Supervisor Katie Ric
3/27/15 - NephroGenex Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2014 [Health & Beauty Close - Up]
NephroGenex, Inc. reported financial results and business highlights for the fourth quarter and year ended December 31, 2014. "NephroGenex achieved important milestones in 2014, including a successful initial public offering, the launch and advancement of our pivotal Phase 3 PIONEER program evaluating Pyridorin in diabetic nephropathy, a favorable
3/27/15 - New Findings from Creighton University in the Area of Drug Discovery Reported (Principles and applications of Raman spectroscopy in pharmaceutical...
New Findings from Creighton University in the Area of Drug Discovery Reported. According to news originating from Omaha, Nebraska, by NewsRx correspondents, research stated, "In recent years, Raman spectroscopy has become increasingly important as an analytical technique in various scientific areas of research and development. Our news journalists.
3/27/15 - Patent Issued for Crystalline Forms of a Macrolide, and Uses Therefor
By a News Reporter-Staff News Editor at Drug Week A patent by the inventor Pereira, David E., filed on March 22, 2011, was published online on March 10, 2015, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents. Patent number 8975386 is assigned to Cempra Pharmaceuticals, Inc.. The following quote was obtai
3/27/15 - PierianDx Debuts PDx Score [Health & Beauty Close - Up]
PierianDx also announced the addition of clinical trials, FDA drug labels, and treatment guidelines from the National Comprehensive Cancer Network and the American Society of Clinical Oncology to its knowledgebase. Inc. into the database are molecular matching to clinical trials, FDA drug labels, and treatment guidelines from NCCN and ASCO.
3/27/15 - PPD, a Leading Global Contract Research Organization, Reduces Costs of Clinical Trials by Migrating Data to the Oracle Health Sciences Cloud
PPD is the first CRO to migrate trials from an onsite installation of Oracle's Siebel Clinical Trial Management System to Siebel Clinical Trial Management System Cloud Servicecreating a highly available, centralized-trial database that lowers costs, simplifies the management and improves the accuracy of multi-CRO clinical trial data, and...
3/27/15 - Researchers Submit Patent Application, "Abuse Resistant Forms of Immediate Release Hydrocodone, Method of Use and Method of Making", for Approval
By a News Reporter-Staff News Editor at Drug Week From Washington, D.C., NewsRx journalists report that a patent application by the inventors Shah, Manish S.; DiFalco, Ray J., filed on November 7, 2014, was made available online on March 12, 2015. No assignee for this patent application has been made. News editors obtained the following quote fro
3/27/15 - United States : Alliance for Clinical Trials in Oncology Foundation Selects Oracle Health Sciences Cloud Solutions as the IT Platform for Its 10-Year... [TendersInfo (India)]
United States: Alliance for Clinical Trials in Oncology Foundation Selects Oracle Health Sciences Cloud Solutions as the IT Platform for Its 10- Year Clinical Study. Alliance for Clinical Trials in Oncology Foundation, a nonprofit organization that supports the mission to reduce the impact of cancer, has selected Oracle s Siebel Clinical Trial Mana
3/27/15 - Zogenix Announces First Patient Dosed in Relday Multi-Dose Clinical Study; pSivida Completes Targeted Enrollment of Phase III Trial of Medidur
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 26, 2015.{ nfg} Zogenix, Inc., announced dosing has begun in patients enrolled in its Relday? multi-dose Phase 1 b clinical study. Relday is a proprietary, long-acting, subcutaneously injected formulation of risperidone being investigated for t
3/26/15 - Abbott Updates on MitraClip System Clinical Trial Data from Initial Commercial Use [Professional Services Close - Up]
Abbot reported outcomes from the initial commercial experience of transcatheter mitral valve repair with MitraClip in the United States, during the late-breaking clinical trial session at the American College of Cardiology's 64th Annual Scientific Session& Expo. Abbot reported that in the study, a transcatheter valve therapy registry formed from a.
3/26/15 - ACADIA Pharmaceuticals Appoints Daniel Soland to Board of Directors
ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that Daniel Soland has joined its Board of Directors. Mr. Soland previously served as Senior Vice President..
3/26/15 - Aduro Receives Orphan Drug Designation for CRS-207 in Mesothelioma
Aduro Biotech, Inc. today announced that the Office of Orphan Product Development of the U.S. Food and Drug Administration has granted orphan drug designation to CRS-207, a novel immuno-oncology product candidate, for the treatment of mesothelioma. This designation potentially allows Aduro seven years of limited marketing exclusivity in the United.
3/26/15 - Advaxis to Present at the Jefferies Immuno-Oncology Summit
Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, announced today that it will present at the 2015 Jefferies Immuno-Oncology Summit being held April 15, 2015 at the Boston Harbor Hotel in Boston, Massachusetts. Advaxis is a clinical-stage biotechnology company developing multiple cancer immunotherapies based
3/26/15 - Agile Therapeutics Reports Fourth Quarter and Full Year 2014 Financial Results
Agile Therapeutics, Inc., a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, today reported financial results for the fourth quarter and year ended December 31, 2014. In November 2014, expanded its Board of Directors with the appointment of John Hubbard, P
3/26/15 - Aldeyra Therapeutics Opens Enrollment in Noninfectious Anterior Uveitis Phase II Clinical Trial
Aldeyra Therapeutics, Inc., a biotechnology company focused on the development of products to treat diseases related to free aldehydes, today announced that it has opened enrollment for its Phase II clinical trial of NS2 for patients with noninfectious anterior uveitis. Stephen Foster, a recognized clinical expert in ocular inflammation.
3/26/15 - Aldeyra Therapeutics Opens Enrollment in Noninfectious Anterior Uveitis Phase II Clinical Trial [National News Agency (Lebanon)]
-Aldeyra Therapeutics, Inc., a biotechnology company focused on the development of products to treat diseases related to free aldehydes, today announced that it has opened enrollment for its Phase II clinical trial of NS2 for patients with noninfectious anterior uveitis. Stephen Foster, a recognized clinical expert in ocular inflammation.
3/26/15 - Alkermes to Present Data on Aripiprazole Lauroxil and ALKS 3831 at 15th International Congress on Schizophrenia Research [Health & Beauty Close - Up]
Alkermes reported that clinical data on aripiprazole lauroxil, an investigational, novel, long-acting injectable atypical antipsychotic for the treatment of schizophrenia, and ALKS 3831, an investigational, novel, oral atypical antipsychotic drug candidate designed to be a broad-spectrum treatment for schizophrenia, are scheduled to be presented at
3/26/15 - Alliance for Clinical Trials in Oncology Foundation Selects Oracle Health Sciences Cloud Solutions as the IT Platform for Its 10-Year Clinical Study
Release date- 25032015- ORACLE INDUSTRY CONNECT, WASHINGTON DC- Alliance for Clinical Trials in Oncology Foundation, a nonprofit organization that supports the mission to reduce the impact of cancer, has selected Oracle's Siebel Clinical Trial Management System and Oracle Health Sciences IRT as the IT platform for a comprehensive, 10- year clinical
3/26/15 - Alnylam Pharmaceuticals Assigned Patent
ALEXANDRIA, Va., March 26 Alnylam Pharmaceuticals, Cambridge, Massachusetts, has been assigned a patent developed by 17 co-inventors for "poly polymers for the delivery of oligonucleotides." The co-inventors are Stephanie E. Barrett, Perkasie, Pennsylvania, Marina Busuek, Center Valley, Pennsylvania, Steven L. Colletti, Princeton Junction, New Je
3/26/15 - Alnylam Pharmaceuticals Assigned Patent for Hepatitis C dsRNA Effector Molecules, Expression Constructs, Compositions, and Methods of Use
ALEXANDRIA, Va., March 26 Alnylam Pharmaceuticals, Cambridge, Massachusetts, has been assigned a patent developed by Daniel McCallus, Cambridge, Massachusetts, and Catherine Pachuk, Cambridge, Massachusetts, for "hepatitis C dsRNA effector molecules, expression constructs, compositions, and methods of use." The patent application was filed on Nov
3/26/15 - Alseres Pharmaceuticals Assigned Patent
ALEXANDRIA, Va., March 26 Alseres Pharmaceuticals, Hopkinton, Massachusetts, has been assigned a patent developed by four co-inventors for "labeled iodinated tropane formulation." The co-inventors are Chris Sterzinger, Vancouver, Canada, Cara Ferreira, Vancouver, Canada, David Leyh, Vancouver, Canada, and Richard Thorn, Boston. Written by Kusum S
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2015 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Lupus: What You Need to Know
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part II: Psychiatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415